TARGET M0035471230Recalls & reported problems
Stryker Corporation · 360 Soft Detachable Coil · Class 2 · Implant
All models of TARGET (114)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 07613252192671), received between Mar 29, 2019 and Jan 8, 2026 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Break” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Break1
- Fracture1
- Premature Separation1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 8, 2026Fracture
IT WAS REPORTED THAT DURING MIDDLE CEREBRAL ARTERY (MCA) ANEURYSM PROCEDURE, THE OPERATOR POSITIONED THE LONG SHEATH AND INTERMEDIATE CATHETER AND SUPER-SELECTIVELY ADVANCED ONE MICROCATHETER TO THE DISTAL M2 SEGMENT TO SERVE AS THE STENT MICROCATHETER, WHILE ANOTHER MICROCATHETER WAS DELIVERED TO THE ANEURYSM SITE. A SUBJECT COIL WAS THEN INTRODUCED. DURING THE DELIVERY PROCESS, THE OPERATOR FELT RESISTANCE AND WITHDREW THE SUBJECT COIL, DISCOVERING THAT ITS TIP HAD FRACTURED. THE OPERATOR THEN WITHDREW THE ENTIRE COIL MICROCATHETER, WITH THE FRACTURED PORTION OF THE SUBJECT COIL REMAINING INSIDE. THE SUBJECT DEVICE WAS REPLACED, AND THE PROCEDURE WAS COMPLETED SUCCESSFULLY. NO CLINICAL CONSEQUENCES WERE REPORTED TO THE PATIENT DUE TO THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24015940 ↗MalfunctionFeb 22, 2022Premature Separation; Premature Separation
ANALYSIS OF THE RETURNED DEVICE FOUND THAT THE SUBJECT COIL DEPLOYED PREMATURELY DURING USE. THERE WERE NO CLINICAL CONSEQUENCES TO THE PATIENT REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13579166 ↗MalfunctionMar 29, 2019Break; Break
IT WAS REPORTED THAT DURING AN ANEURYSM CASE, WHEN ADVANCING THE SUBJECT COIL INSIDE THE MICROCATHETER, THE RESISTANCE WAS ENCOUNTERED, THEREFORE; THE SUBJECT COIL WAS WITHDRAWN, AND IT WAS FOUND TO BE BROKEN IN THE MICROCATHETER. THE SUBJECT COIL AND MICROCATHETER WERE REMOVED TOGETHER AS A UNIT. THE OPERATOR REPLACED THEM WITH A NEW MICROCATHETER AND NEW COIL TO FINISH THE PROCEDURE. THERE WERE NO CLINICAL CONSEQUENCES TO THE PATIENT DUE TO THE REPORTED EVENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8467126 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page